These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3816985)

  • 21. Acute and chronic effects of serotonin (5HT) antagonists on serotonin binding sites.
    Blackshear MA; Friedman RL; Sanders-Bush E
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):125-9. PubMed ID: 6646240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels.
    Roth BL; Ciaranello RD
    Eur J Pharmacol; 1991 Jun; 207(2):169-72. PubMed ID: 1879460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [3H]Mianserin: differential labeling of serotonin and histamine receptors in rat brain.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1981 Jan; 216(1):142-8. PubMed ID: 6109019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.
    Sanders-Bush E; Breeding M
    J Pharmacol Exp Ther; 1988 Oct; 247(1):169-73. PubMed ID: 3139864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.
    Whiteford HA; Jarvis MR; Stedman TJ; Pond S; Csernansky JG
    Life Sci; 1993; 53(4):371-6. PubMed ID: 8326822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels.
    Rocha B; Rigo M; Di Scala G; Sandner G; Hoyer D
    Eur J Pharmacol; 1994 Sep; 262(1-2):125-31. PubMed ID: 7813563
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic control of dopamine and serotonin receptors in brain regions of inbred mice.
    Boehme RE; Ciaranello RD
    Brain Res; 1983 Apr; 266(1):51-65. PubMed ID: 6850346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
    Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
    Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine.
    Wikström HV; Mensonides-Harsema MM; Cremers TI; Moltzen EK; Arnt J
    J Med Chem; 2002 Jul; 45(15):3280-5. PubMed ID: 12109911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [3H]Mianserin binding to solubilized membranes of frontal cortex.
    Chan B; Madras BK
    Eur J Pharmacol; 1982 Sep; 83(1-2):1-10. PubMed ID: 7128693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2,3-Dialkyl(dimethylamino)indoles: interaction with 5HT1, 5HT2, and rat stomach fundal serotonin receptors.
    Fludzinski P; Wittenauer LA; Schenck KW; Cohen ML
    J Med Chem; 1986 Nov; 29(11):2415-8. PubMed ID: 3783602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
    Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
    Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antagonistic effects of some metabolites and analogues of mianserin on serotonin and alpha 1- and alpha 2-adrenergic receptors in the flexor reflex model in vivo.
    Przegaliński E; Rawłów A; Dohnal-Borak I
    Pol J Pharmacol Pharm; 1986; 38(1):69-75. PubMed ID: 3020532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple serotonin receptors: regional distribution and effect of Raphe lesions.
    Blackshear MA; Steranka LR; Sanders-Bush E
    Eur J Pharmacol; 1981 Dec; 76(4):325-34. PubMed ID: 7327207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Temperature-dependent 5-hydroxytryptamine (5-HT)-sensitive [3H]spiperone binding to rat cortical membranes: regulation by guanine nucleotide and antidepressant treatment.
    Kendall DA; Nahorski SR
    J Pharmacol Exp Ther; 1983 Nov; 227(2):429-34. PubMed ID: 6631722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of D2 dopamine receptors in different brain regions.
    Leonard MN; Macey CA; Strange PG
    Biochem J; 1987 Dec; 248(2):595-602. PubMed ID: 2963621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptor pharmacology of MDMA and related hallucinogens.
    Teitler M; Leonhardt S; Appel NM; De Souza EB; Glennon RA
    Ann N Y Acad Sci; 1990; 600():626-38; discussion 638-9. PubMed ID: 1979215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.